Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 84 articles:
HTML format
Text format



Single Articles


    September 2017
  1. CHANG CL, Tsai HC, Lin WC, Chang JH, et al
    Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
    Radiother Oncol. 2017 Sep 15. pii: S0167-8140(17)32548.
    PubMed     Text format     Abstract available


  2. SHIRAISHI Y, Xu C, Yang J, Komaki R, et al
    Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
    Radiother Oncol. 2017 Sep 13. pii: S0167-8140(17)32550.
    PubMed     Text format     Abstract available


    August 2017
  3. YANG H, Chen X, Lin S, Rong J, et al
    Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Radiother Oncol. 2017 Aug 29. pii: S0167-8140(17)32479.
    PubMed     Text format     Abstract available


  4. LOCK S, Perrin R, Seidlitz A, Bandurska-Luque A, et al
    Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging.
    Radiother Oncol. 2017 Aug 23. pii: S0167-8140(17)32517.
    PubMed     Text format     Abstract available


  5. FERRIS MJ, Zhong J, Switchenko JM, Higgins KA, et al
    Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy.
    Radiother Oncol. 2017 Aug 18. pii: S0167-8140(17)32515.
    PubMed     Text format     Abstract available


  6. TONLAAR N, Galoforo S, Thibodeau BJ, Ahmed S, et al
    Antitumor activity of the dual PI3K/MTOR inhibitor, PF-04691502, in combination with radiation in head and neck cancer.
    Radiother Oncol. 2017 Aug 16. pii: S0167-8140(17)32501.
    PubMed     Text format     Abstract available


  7. HAWKINS PG, Lee JY, Mao Y, Li P, et al
    Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life.
    Radiother Oncol. 2017 Aug 16. pii: S0167-8140(17)32502.
    PubMed     Text format     Abstract available


  8. HUIZING FJ, Hoeben BAW, Franssen G, Lok J, et al
    Preclinical validation of 111In-girentuximab-F(ab')2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts.
    Radiother Oncol. 2017 Aug 5. pii: S0167-8140(17)32484.
    PubMed     Text format     Abstract available


    July 2017
  9. MOHAMED ASR, Cardenas CE, Garden AS, Awan MJ, et al
    Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
    Radiother Oncol. 2017 Jul 31. pii: S0167-8140(17)32476.
    PubMed     Text format     Abstract available


  10. ZHAI TT, van Dijk LV, Huang BT, Lin ZX, et al
    Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters.
    Radiother Oncol. 2017 Jul 29. pii: S0167-8140(17)32472.
    PubMed     Text format     Abstract available


  11. NEVENS D, Duprez F, Bonte K, Deron P, et al
    Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Tumor control and late toxicity.
    Radiother Oncol. 2017 Jul 26. pii: S0167-8140(17)32470.
    PubMed     Text format     Abstract available


  12. NEVENS D, Duprez F, Daisne JF, De Neve W, et al
    Dose de-escalation to the elective lymph nodes in head and neck cancer. Reply to Amdur et al.
    Radiother Oncol. 2017 Jul 24. pii: S0167-8140(17)32456.
    PubMed     Text format    


  13. RASSAMEGEVANON T, Lock S, Range U, Krause M, et al
    Tumor heterogeneity determined with a gammaH2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models.
    Radiother Oncol. 2017 Jul 21. pii: S0167-8140(17)32447.
    PubMed     Text format     Abstract available


  14. XI M, Xu C, Liao Z, Hofstetter WL, et al
    The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.
    Radiother Oncol. 2017 Jul 4. pii: S0167-8140(17)30428.
    PubMed     Text format     Abstract available


    June 2017
  15. ZHANG D, Zhang W, Liu W, Mao Y, et al
    Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.
    Radiother Oncol. 2017 Jun 21. pii: S0167-8140(17)30408.
    PubMed     Text format     Abstract available


  16. MCLAY M, Stedford A, Yurkowski E, Matlock S, et al
    Population-based assessment of relationship between volume of practice and outcomes in head and neck cancer patients treated in a provincially coordinated radiotherapy program.
    Radiother Oncol. 2017 Jun 15. pii: S0167-8140(17)30401.
    PubMed     Text format     Abstract available


    May 2017
  17. KOPPENHAGEN P, Dickreuter E, Cordes N
    Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin.
    Radiother Oncol. 2017 May 31. pii: S0167-8140(17)30375.
    PubMed     Text format     Abstract available


  18. CHEN J, Cai W, Zheng X, Chen Y, et al
    The pattern of cervical lymph node metastasis in thoracic esophageal squamous cell carcinoma may affect the target decision for definitive radiotherapy.
    Radiother Oncol. 2017 May 24. pii: S0167-8140(17)30152.
    PubMed     Text format     Abstract available


  19. LAI TY, Wang TH, Liu CJ, Chao TF, et al
    Risk factors for osteonecrosis of the jaw in oral cancer patients after surgery and eventual adjuvant treatment: The potential role of chemotherapy.
    Radiother Oncol. 2017 May 19. pii: S0167-8140(17)30362.
    PubMed     Text format     Abstract available


  20. FAN CY, Lin CS, Chao HL, Huang WY, et al
    Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study.
    Radiother Oncol. 2017 May 19. pii: S0167-8140(17)30367.
    PubMed     Text format     Abstract available


  21. CHRISTIAENS M, Collette S, Overgaard J, Gregoire V, et al
    Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure.
    Radiother Oncol. 2017 May 4. pii: S0167-8140(17)30160.
    PubMed     Text format     Abstract available


    April 2017
  22. LIN SH, Merrell KW, Shen J, Verma V, et al
    Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer.
    Radiother Oncol. 2017 Apr 25. pii: S0167-8140(17)30154.
    PubMed     Text format     Abstract available


  23. WELZ S, Monnich D, Pfannenberg C, Nikolaou K, et al
    Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial.
    Radiother Oncol. 2017 Apr 20. pii: S0167-8140(17)30144.
    PubMed     Text format     Abstract available


  24. RUSTHOVEN CG, Lanning RM, Jones BL, Amini A, et al
    Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy.
    Radiother Oncol. 2017 Apr 19. pii: S0167-8140(17)30130.
    PubMed     Text format     Abstract available


  25. ZHU H, Song H, Chen G, Yang X, et al
    eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma.
    Radiother Oncol. 2017 Apr 18. pii: S0167-8140(17)30140.
    PubMed     Text format     Abstract available


  26. YAMASHITA H, Abe O, Nakagawa K
    Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of 18FDG-PET scans: A long follow-up results of phase II study.
    Radiother Oncol. 2017 Apr 17. pii: S0167-8140(17)30141.
    PubMed     Text format    


    March 2017
  27. NEVENS D, Duprez F, Daisne JF, Schatteman J, et al
    Recurrence patterns after a decreased dose of 40Gy to the elective treated neck in head and neck cancer.
    Radiother Oncol. 2017 Mar 22. pii: S0167-8140(17)30099.
    PubMed     Text format     Abstract available


  28. LIGTENBERG H, Jager EA, Caldas-Magalhaes J, Schakel T, et al
    Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI.
    Radiother Oncol. 2017 Mar 1. pii: S0167-8140(17)30064.
    PubMed     Text format     Abstract available


    February 2017
  29. ZSCHAECK S, Lock S, Leger S, Haase R, et al
    FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
    Radiother Oncol. 2017 Feb 17. pii: S0167-8140(17)30047.
    PubMed     Text format     Abstract available


  30. BERTHON B, Evans M, Marshall C, Palaniappan N, et al
    Head and neck target delineation using a novel PET automatic segmentation algorithm.
    Radiother Oncol. 2017;122:242-247.
    PubMed     Text format     Abstract available


  31. VAN LOON J, Even AJ, Aerts HJ, Ollers M, et al
    PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer.
    Radiother Oncol. 2017;122:267-273.
    PubMed     Text format     Abstract available


  32. BUSCH CJ, Kroger MS, Jensen J, Kriegs M, et al
    G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1.
    Radiother Oncol. 2017;122:260-266.
    PubMed     Text format     Abstract available


  33. KOVACS G, Martinez-Monge R, Budrukkar A, Guinot JL, et al
    GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update - Improvement by cross sectional imaging based treatment planning and stepping source technology.
    Radiother Oncol. 2017;122:248-254.
    PubMed     Text format     Abstract available


    January 2017
  34. PATEL R, Barker HE, Kyula J, McLaughlin M, et al
    An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation.
    Radiother Oncol. 2017 Jan 25. pii: S0167-8140(16)34478.
    PubMed     Text format     Abstract available


  35. FUCCIO L, Mandolesi D, Farioli A, Hassan C, et al
    Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies.
    Radiother Oncol. 2017 Jan 16. pii: S0167-8140(17)30003.
    PubMed     Text format     Abstract available


    November 2016
  36. THOR M, Owosho AA, Clark HD, Oh JH, et al
    Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer.
    Radiother Oncol. 2016 Nov 24. pii: S0167-8140(16)34380.
    PubMed     Text format     Abstract available


  37. LESZCZYNSKA KB, Dobrynin G, Leslie RE, Ient J, et al
    Preclinical testing of an Atr inhibitor demonstrates improved response to standard therapies for esophageal cancer.
    Radiother Oncol. 2016 Nov 10. pii: S0167-8140(16)34372.
    PubMed     Text format     Abstract available


  38. WANG L, Liu L, Han C, Liu S, et al
    The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Radiother Oncol. 2016 Nov 9. pii: S0167-8140(16)34370.
    PubMed     Text format     Abstract available


    October 2016
  39. QIU B, Wang D, Yang H, Xie W, et al
    Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma.
    Radiother Oncol. 2016 Oct 25. pii: S0167-8140(16)34352.
    PubMed     Text format     Abstract available


  40. MARTINEZ-FERNANDEZ MI, Alcalde J, Cambeiro M, Peydro GV, et al
    Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study.
    Radiother Oncol. 2016 Oct 13. pii: S0167-8140(16)34287.
    PubMed     Text format     Abstract available


    August 2016
  41. HE L, Chapple A, Liao Z, Komaki R, et al
    Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.
    Radiother Oncol. 2016 Aug 22. pii: S0167-8140(16)31243.
    PubMed     Text format     Abstract available


  42. NEVENS D, Duprez F, Daisne JF, Dok R, et al
    Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control.
    Radiother Oncol. 2016 Aug 12. pii: S0167-8140(16)34247.
    PubMed     Text format     Abstract available


  43. CHUTER R, Prestwich R, Bird D, Scarsbrook A, et al
    The use of deformable image registration to integrate diagnostic MRI into the radiotherapy planning pathway for head and neck cancer.
    Radiother Oncol. 2016 Aug 3. pii: S0167-8140(16)31212.
    PubMed     Text format     Abstract available


    July 2016
  44. LOIMU V, Seppala T, Kapanen M, Tuomikoski L, et al
    Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Radiother Oncol. 2016 Jul 27. pii: S0167-8140(16)31200.
    PubMed     Text format     Abstract available


  45. WONG KH, Kuciejewska A, Sharabiani MT, Ng-Cheng-Hin B, et al
    A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer.
    Radiother Oncol. 2016 Jul 5. pii: S0167-8140(16)31174.
    PubMed     Text format     Abstract available


    June 2016
  46. BROUWER CL, Steenbakkers RJ, van der Schaaf A, Sopacua CT, et al
    Selection of head and neck cancer patients for adaptive radiotherapy to decrease xerostomia.
    Radiother Oncol. 2016 Jun 23. pii: S0167-8140(16)31149.
    PubMed     Text format     Abstract available


  47. LIN P, Min M, Lee M, Holloway L, et al
    Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.
    Radiother Oncol. 2016 Jun 16. pii: S0167-8140(16)31124.
    PubMed     Text format     Abstract available


  48. MATUSCHEK C, Bolke E, Geigis C, Kammers K, et al
    Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients.
    Radiother Oncol. 2016 Jun 10. pii: S0167-8140(16)31120.
    PubMed     Text format     Abstract available


    May 2016
  49. CHEN CY, Li CC, Chien CR
    Does higher radiation dose lead to better outcome for non-operated localized esophageal squamous cell carcinoma patients who received concurrent chemoradiotherapy? A population based propensity-score matched analysis.
    Radiother Oncol. 2016 May 17. pii: S0167-8140(16)31089.
    PubMed     Text format     Abstract available


  50. KJAER T, Dalton SO, Andersen E, Karlsen R, et al
    A controlled study of use of patient-reported outcomes to improve assessment of late effects after treatment for head-and-neck cancer.
    Radiother Oncol. 2016 May 10. pii: S0167-8140(16)31080.
    PubMed     Text format     Abstract available


  51. JANSSENS GO, Langendijk JA, Terhaard CH, Doornaert PA, et al
    Quality-of-life after radiotherapy for advanced laryngeal cancer: Results of a phase III trial of the Dutch Head and Neck Society.
    Radiother Oncol. 2016 May 7. pii: S0167-8140(16)00111.
    PubMed     Text format     Abstract available


    April 2016
  52. TOL JP, Doornaert P, Witte BI, Dahele M, et al
    A longitudinal evaluation of improvements in radiotherapy treatment plan quality for head and neck cancer patients.
    Radiother Oncol. 2016 Apr 26. pii: S0167-8140(16)31045.
    PubMed     Text format     Abstract available


  53. MOSLEMI D, Nokhandani AM, Otaghsaraei MT, Moghadamnia Y, et al
    Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer: A review of the current literature.
    Radiother Oncol. 2016 Apr 21. pii: S0167-8140(16)31035.
    PubMed     Text format     Abstract available


  54. WANG JZ, Li JB, Qi HP, Li YK, et al
    Effect of contrast enhancement in delineating GTV and constructing IGTV of thoracic oesophageal cancer based on 4D-CT scans.
    Radiother Oncol. 2016;119:172-8.
    PubMed     Text format     Abstract available


  55. DEAN JA, Welsh LC, McQuaid D, Wong KH, et al
    Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk.
    Radiother Oncol. 2016;119:166-71.
    PubMed     Text format     Abstract available


  56. PALMA B, Bazalova-Carter M, Hardemark B, Hynning E, et al
    Assessment of the quality of very high-energy electron radiotherapy planning.
    Radiother Oncol. 2016;119:154-8.
    PubMed     Text format     Abstract available


  57. TAKANAMI K, Arai A, Umezawa R, Takeuchi T, et al
    Association between radiation dose to the heart and myocardial fatty acid metabolic impairment due to chemoradiation-therapy: Prospective study using I-123 BMIPP SPECT/CT.
    Radiother Oncol. 2016;119:77-83.
    PubMed     Text format     Abstract available


    March 2016
  58. MACFARLANE M, Hoover DA, Wong E, Read N, et al
    Evaluation of unified intensity-modulated arc therapy for the radiotherapy of head-and-neck cancer.
    Radiother Oncol. 2016 Mar 31. pii: S0167-8140(16)31017.
    PubMed     Text format     Abstract available


  59. ELICIN O, Nisa L, Dal Pra A, Bojaxhiu B, et al
    Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: Rationale, complications, toxicity rates, and oncological outcomes - A systematic review.
    Radiother Oncol. 2016 Mar 17. pii: S0167-8140(16)00125.
    PubMed     Text format     Abstract available


  60. RASMUSSEN JH, Hakansson K, Vogelius IR, Aznar MC, et al
    Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer.
    Radiother Oncol. 2016 Mar 15. pii: S0167-8140(16)00127.
    PubMed     Text format     Abstract available


  61. JIN P, Hulshof MC, de Jong R, van Hooft JE, et al
    Quantification of respiration-induced esophageal tumor motion using fiducial markers and four-dimensional computed tomography.
    Radiother Oncol. 2016;118:492-7.
    PubMed     Text format     Abstract available


  62. JANSSENS G, Smeets J, Vander Stappen F, Prieels D, et al
    Sensitivity study of prompt gamma imaging of scanned beam proton therapy in heterogeneous anatomies.
    Radiother Oncol. 2016;118:562-7.
    PubMed     Text format     Abstract available


    February 2016
  63. CHENG Q, Roelofs E, Ramaekers BL, Eekers D, et al
    Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer - Comparison of dose, toxicity and cost-effectiveness.
    Radiother Oncol. 2016 Feb 26. pii: S0167-8140(16)00031.
    PubMed     Text format     Abstract available


  64. HONG A, Zhang X, Jones D, Veillard AS, et al
    Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma.
    Radiother Oncol. 2016;118:342-9.
    PubMed     Text format     Abstract available



  65. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
    Radiother Oncol. 2016;118:304-14.
    PubMed     Text format     Abstract available


  66. LYHNE NM, Johansen J, Kristensen CA, Andersen E, et al
    Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group.
    Radiother Oncol. 2016;118:257-66.
    PubMed     Text format     Abstract available


  67. ROMESSER PB, Cahlon O, Scher E, Zhou Y, et al
    Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
    Radiother Oncol. 2016;118:286-92.
    PubMed     Text format     Abstract available


  68. RICHTER C, Pausch G, Barczyk S, Priegnitz M, et al
    First clinical application of a prompt gamma based in vivo proton range verification system.
    Radiother Oncol. 2016;118:232-7.
    PubMed     Text format     Abstract available


  69. GUJRAL DM, Shah BN, Chahal NS, Bhattacharyya S, et al
    Carotid intima-medial thickness as a marker of radiation-induced carotid atherosclerosis.
    Radiother Oncol. 2016;118:323-9.
    PubMed     Text format     Abstract available


  70. LEE JY, Sun JM, Oh DR, Lim SH, et al
    Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02).
    Radiother Oncol. 2016;118:244-50.
    PubMed     Text format     Abstract available


  71. ZENDA S, Akimoto T, Mizumoto M, Hayashi R, et al
    Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses.
    Radiother Oncol. 2016;118:267-71.
    PubMed     Text format     Abstract available


  72. JENSEN AD, Poulakis M, Nikoghosyan AV, Welzel T, et al
    High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
    Radiother Oncol. 2016;118:272-80.
    PubMed     Text format     Abstract available


    January 2016
  73. MESSER JA, Mohamed AS, Hutcheson KA, Ding Y, et al
    Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics.
    Radiother Oncol. 2016 Jan 28. pii: S0167-8140(16)00033.
    PubMed     Text format     Abstract available


  74. NYQVIST J, Fransson P, Laurell G, Hammerlid E, et al
    Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.
    Radiother Oncol. 2016 Jan 6. pii: S0167-8140(15)00685.
    PubMed     Text format     Abstract available


  75. DONOHOE CL, Reynolds JV
    Letter to the Co-Editors-in-Chief, Radiotherapy and Oncology.
    Radiother Oncol. 2016;118:215.
    PubMed     Text format    


    December 2015
  76. KHAN Z, Khan AA, Prasad GB, Khan N, et al
    Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Radiother Oncol. 2015 Dec 30. pii: S0167-8140(15)00665.
    PubMed     Text format     Abstract available


  77. DE FELICE F, Musio D, Tombolini V
    Mastication structures definition in head and neck cancer.
    Radiother Oncol. 2015 Dec 29. pii: S0167-8140(15)00677.
    PubMed     Text format    


  78. TAWK B, Schwager C, Deffaa O, Dyckhoff G, et al
    Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
    Radiother Oncol. 2015 Dec 19. pii: S0167-8140(15)00647.
    PubMed     Text format     Abstract available


  79. CHRISTIANEN ME, van der Schaaf A, van der Laan HP, Verdonck-de Leeuw IM, et al
    Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach.
    Radiother Oncol. 2015 Dec 14. pii: S0167-8140(15)00613.
    PubMed     Text format     Abstract available


    November 2015
  80. MOON H, Roh JL, Lee SW, Kim SB, et al
    Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Radiother Oncol. 2015 Nov 30. pii: S0167-8140(15)00597.
    PubMed     Text format     Abstract available


  81. BUDACH W, Bolke E, Kammers K, Gerber PA, et al
    Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Radiother Oncol. 2015 Nov 14. pii: S0167-8140(15)00563.
    PubMed     Text format     Abstract available


    July 2015
  82. HUANG W, Huang Y, Sun J, Liu X, et al
    Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China.
    Radiother Oncol. 2015;116:100-6.
    PubMed     Text format     Abstract available


  83. SAMUELS SE, Vainshtein J, Spector ME, Ibrahim M, et al
    Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy.
    Radiother Oncol. 2015;116:75-81.
    PubMed     Text format     Abstract available


  84. KLAASSEN R, Bennink RJ, van Tienhoven G, Bijlsma MF, et al
    Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer.
    Radiother Oncol. 2015;116:94-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: